Evolent Health, Inc. EVH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -507.69M | -504.99M | -496.52M | -534.51M | -128.18M |
| Total Depreciation and Amortization | 86.55M | 88.87M | 90.65M | 92.65M | 54.71M |
| Total Amortization of Deferred Charges | 39.21M | 40.53M | 38.79M | 37.80M | 36.36M |
| Total Other Non-Cash Items | 438.54M | 441.74M | 446.25M | 500.29M | 140.05M |
| Change in Net Operating Assets | 8.28M | -11.83M | -45.87M | -57.38M | -139.13M |
| Cash from Operations | 64.88M | 54.32M | 33.29M | 38.84M | -36.19M |
| Capital Expenditure | -29.62M | -31.37M | -84.84M | -91.53M | -93.80M |
| Sale of Property, Plant, and Equipment | 91.31M | 91.31M | 91.31M | 91.31M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -8.50M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 300.00K | 348.00K | -14.00K | -14.00K | -15.00K |
| Cash from Investing | 61.99M | 60.29M | 6.45M | -233.00K | -102.32M |
| Total Debt Issued | 18.31M | 187.05M | 187.05M | 408.05M | 448.32M |
| Total Debt Repaid | -123.73M | -290.48M | -280.48M | -342.98M | -228.73M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.19M | -42.42M | -42.45M | -45.22M | -45.47M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -1.93M | -6.55M | -11.13M | -15.93M |
| Other Financing Activities | -3.94M | -2.03M | -5.32M | -44.64M | -4.13M |
| Cash from Financing | -112.55M | -149.82M | -147.75M | -35.92M | 154.05M |
| Foreign Exchange rate Adjustments | -1.47M | -1.29M | -1.10M | -486.00K | -397.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.85M | -36.50M | -109.10M | 2.20M | 15.15M |